Home
Conditions
Lung Diseases, Interstitial

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

737 public trials 132 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Recruiting

Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

NCT05842681

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: Assiut university-Faculty of Medicine Asyut, Egypt

Faculty of Medicine Assuit University Asyut, Egypt

View Trial Details

Recruiting

Pirfenidone to Prevent Fibrosis in Ards.

NCT05075161

Conditions: Acute Respiratory Distress Syndrome (ARDS), Fibrosis, Lung Diseases, +7 more
Locations: IRCCS San Raffaele Scientific Institute Milan, MI, Italy

Ospedale Cesare Arrigo Alessandria, Piedmont, Italy

Ospedale Santa Maria Bari, Italy

ASST Spedali Civili di Brescia Brescia, Italy

View all 17 locations

View Trial Details

Recruiting

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

NCT01531257

Conditions: Acute Rejection (AR) of Transplanted Kidney, Chronic Allograft Nephropathy (CAN), Fibrosis, +8 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Recruiting

Advanced Imaging for Pulmonary Fibrosis

NCT06532071

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

NCT07082842

Conditions: Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations: China-Japan Friendship Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

NCT03803787

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations: Instituto Nacional de Cancerologia Mexico City, Mexico

Instituto Nacional de Enfermedades Respiratorias Mexico City, Mexico

View Trial Details

Recruiting

Validation of the C-mo System - Cough Monitoring

NCT05989698

Conditions: Asthma, Bronchial Diseases, Chronic Disease, +29 more
Locations: HPAV - Trofa Saúde Hospital de Alfena Alfena, Portugal

HFF - Hospital Professor Doutor Fernando Fonseca Amadora, Portugal

Lab3R - Laboratório de Investigação e Reabilitação Respiratória da Escola Superior de Saúde da Universidade de Aveiro Aveiro, Portugal

CHUC - Centro Hospitalar e Universitário de Coimbra Coimbra, Portugal

View Trial Details

Recruiting

Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib

NCT06582745

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations: Cook Children's Health Care System Fort Worth, Texas, United States

View Trial Details

Recruiting

Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis

NCT04871191

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +13 more
Locations: Hôpital de la Croix Saint Simon Paris, France

View Trial Details

Recruiting

Optimization of the Time and Dosage of Vemurafenib in BRAF Positive Juvenile Patients With Refractory Histiocytosis

NCT04943198

Conditions: Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +4 more
Locations: Mother and Child Institute Warsaw, Mazovian, Poland

View Trial Details

Lung Diseases, Interstitial

Lung Diseases, Interstitial trial results

Related conditions